Research on immunotherapy approaches for cancer

From November 2025

Macrophage-targeted immunocytokines enhance synergy among immune cells in cancer therapy, ref: von Locquenghien doi.org/10.1016/j.cell.2025.10.030/
Peptibody mRNA delivery of antimicrobial peptides shows superior efficacy against multidrug-resistant pneumonia, ref: Xue doi.org/10.1038/s41587-025-02928-x/
Sacituzumab tirapazamine demonstrates promising activity in advanced urothelial carcinoma after prior therapies, ref: Zhu doi.org/10.1016/j.annonc.2025.11.013/
Spatial transcriptomics reveal distinct programs in lung adenocarcinoma progression, ref: Peng doi.org/10.1016/j.ccell.2025.10.004/
Local consolidative therapy combined with immunotherapy improves survival in NSCLC patients, ref: Yang doi.org/10.1038/s41392-025-02460-z/
FABP4 identified as a prognostic marker for HCC related to metabolic dysfunction, ref: Zhang doi.org/10.1016/j.jhep.2025.10.026/
IL-12-releasing nanoparticles enhance therapeutic efficacy in metastatic ovarian cancer, ref: Pires doi.org/10.1038/s41563-025-02390-9/
Targeting VISTA enhances anti-tumor immunotherapy, highlighting new avenues for overcoming resistance, ref: Chen doi.org/10.1038/s41422-025-01194-5/

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec